宫颈弥漫性原发性大B细胞淋巴瘤。关于一个案件

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Clinica e Investigacion en Ginecologia y Obstetricia Pub Date : 2023-10-01 DOI:10.1016/j.gine.2023.100886
B. Pando Ruiz , I. Gonzalo García , L.M. Fernández Abad
{"title":"宫颈弥漫性原发性大B细胞淋巴瘤。关于一个案件","authors":"B. Pando Ruiz ,&nbsp;I. Gonzalo García ,&nbsp;L.M. Fernández Abad","doi":"10.1016/j.gine.2023.100886","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.</p></div><div><h3>Clinical findings</h3><p>The patient presented is a 72-year-old woman who consulted for vaginal bleeding.</p></div><div><h3>Diagnosis</h3><p>Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype<!--> <!-->B of high cytological grade and high proliferative index was diagnosed.</p></div><div><h3>Therapeutic interventions and results</h3><p>The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5<!--> <!-->years. It is currently being monitored by carrying out annual analytical controls.</p></div><div><h3>Conclusion</h3><p>The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.</p><p>It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.</p><p>The prognosis is generally good, with up to 80% survival at 5<!--> <!-->years.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Linfoma difuso de células B grandes primario de cérvix. A propósito de un caso\",\"authors\":\"B. Pando Ruiz ,&nbsp;I. Gonzalo García ,&nbsp;L.M. Fernández Abad\",\"doi\":\"10.1016/j.gine.2023.100886\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.</p></div><div><h3>Clinical findings</h3><p>The patient presented is a 72-year-old woman who consulted for vaginal bleeding.</p></div><div><h3>Diagnosis</h3><p>Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype<!--> <!-->B of high cytological grade and high proliferative index was diagnosed.</p></div><div><h3>Therapeutic interventions and results</h3><p>The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5<!--> <!-->years. It is currently being monitored by carrying out annual analytical controls.</p></div><div><h3>Conclusion</h3><p>The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.</p><p>It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.</p><p>The prognosis is generally good, with up to 80% survival at 5<!--> <!-->years.</p></div>\",\"PeriodicalId\":41294,\"journal\":{\"name\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210573X23000564\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X23000564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

引言非霍奇金淋巴瘤原发性累及女性生殖道的情况非常罕见,因此在治疗上没有达成共识,因此我们介绍了这一临床病例、所进行的治疗以及患者的预后。临床发现患者是一名72岁的女性,因阴道出血就诊。诊断原发性宫颈结外非霍奇金淋巴瘤,免疫表型为B型,细胞学分级高,增殖指数高。治疗干预措施和结果选择的治疗方法仅为化疗。该患者的无病生存期为5年。目前正在通过进行年度分析控制对其进行监测。结论该类型肿瘤的症状高度非特异性,细胞学检查经常为阴性,这就是为什么有必要进行活检的原因。免疫组织化学对诊断和预后都至关重要。有多种成像技术用于扩展研究和随访,突出了FDG-PET的作用。目前看来,最推荐的治疗方法是R-CHOP化疗方案,然后是放疗。预后一般良好,5年生存率高达80%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Linfoma difuso de células B grandes primario de cérvix. A propósito de un caso

Introduction

Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.

Clinical findings

The patient presented is a 72-year-old woman who consulted for vaginal bleeding.

Diagnosis

Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype B of high cytological grade and high proliferative index was diagnosed.

Therapeutic interventions and results

The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5 years. It is currently being monitored by carrying out annual analytical controls.

Conclusion

The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.

It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.

The prognosis is generally good, with up to 80% survival at 5 years.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
54
期刊介绍: Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.
期刊最新文献
Descripción de un caso: liposarcoma de mama radioinducido Update on second trimester ultrasound scanning in pregnancy Perinatal outcomes in pregnant women over 45 years old: Singleton or multiple pregnancy? Obstetric anal sphincter injuries (OASIS) incidence. Twenty-five years’ evolution Preconceptional micronutrient supplementation and spontaneous pregnancy rates in women of higher reproductive age and unexplained infertility: A comparative study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1